Zhongsheng Tong

机构：South China Agricultural University, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University · ORCID：0000-0001-8060-5699

发表论文 212 篇 · 总被引 5264 次 · h-index 32

代表论文

• Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01 (2024 · Journal of Clinical Oncology · 被引 163)
• Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial (2025 · Nature Medicine · 被引 53)
• LBA23 Sacituzumab tirumotecan (sac-TMT) vs investigator's choice of chemotherapy (ICC) in previously treated locally advanced or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer (BC): Results from the randomized, multi-center phase III OptiTROP-Breast02 study (2025 · Annals of Oncology · 被引 6)
• An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial (2025 · 癌症：英文版 · 被引 5)
• Design and experiment for automatic row-alignment harvesting method of cotton picker based on contact sensor and GNSS/IMU fusion (2025 · Computers and Electronics in Agriculture · 被引 4)
• Abstract PS3-08: Interim Overall Survival of Patients with Locally Advanced or Metastatic Triple-Negative Breast Cancer treated with First Line PM8002/BNT327 in Combination with Nab-Paclitaxel in Phase Ib/II Study (2025 · Clinical Cancer Research · 被引 4)